IL5 and ocular melanoma: The hydrolysates of OVA and OM with pepsin and alcalase exerted a dose-dependent inhibition of the release of IL-13 and IL-5 induced by previous anti-CD40 and IL-4 conditioning, which was significant, particularly at the highest doses (Fig 1a and 1b).